{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:59:51Z","timestamp":1781614791218,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Bacterial infections and antimicrobial resistance constitute significant threats to global human health, resulting in millions of fatalities annually. The development of innovative diagnostic agents is essential to facilitate precision medicine approaches in the battle against infectious diseases. Infection imaging using radiolabeled antimicrobial peptides (AMP) has emerged as a promising approach to detect bacterial infections. UBI(29\u201341), an AMP fragment, exhibits binding to bacterial cell membranes. Conjugated to chelators, UBI(29\u201341) has been labeled with radiometals such as\n                      <jats:sup>99m<\/jats:sup>\n                      Tc or\n                      <jats:sup>68<\/jats:sup>\n                      Ga, and proven its ability to differentiate between sterile inflammation and infection with S. aureus by imaging. Due to its physical properties,\n                      <jats:sup>18<\/jats:sup>\n                      F is more favorable for PET\/CT imaging. As peptide labeling with\n                      <jats:sup>18<\/jats:sup>\n                      F is challenging, we here implemented the Al\n                      <jats:sup>18<\/jats:sup>\n                      F labeling approach. This study aims to develop an optimized, fully automated, GMP-compliant process for radiolabeling of NOTA-conjugated UBI(29\u201341) with Al\n                      <jats:sup>18<\/jats:sup>\n                      F for PET\/CT imaging of infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Optimized reaction conditions led to the establishment of a robust Al\n                      <jats:sup>18<\/jats:sup>\n                      Fcomplexation protocol, which was implemented on a SynChrom R&amp;D module. The labeling reaction was carried out in an acidic medium (pH\u00a04.0) at 105\u00a0\u00b0C for 15\u00a0min, followed by a two-step HPLC purification for 20\u00a0min. Optimization of reagent concentrations enabled an activity yield up to 10\u2009\u00b1\u20091\u00a0GBq, with a radiochemical yield of 24.2\u2009\u00b1\u20090.6% and an apparent molar activity of 45\u2009\u00b1\u20094\u00a0GBq\/\u00b5mol at end of synthesis (EOS) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093). The radiochemical purity was 96.6\u2009\u00b1\u20090.3% as determined by analytical HPLC, using UV absorption (220\u00a0nm). Quality control was successfully established using validated analytical procedures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The developed GMP-compliant radiolabelling process yields reproducible results with sufficient activities for further translation and investigations of clinical PET\/CT imaging using Al[\n                      <jats:sup>18<\/jats:sup>\n                      F]F-NOTA-UBI(29\u201341) in infectious diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41181-025-00370-7","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:56:05Z","timestamp":1753703765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimization of a GMP-compliant automated one-pot synthesis of Al[18F]F-NOTA-Ubiquicidin29\u2009\u2212\u200941 for bacterial infection imaging by PET\/CT"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8233-3747","authenticated-orcid":false,"given":"Anna","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Moosbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"2","key":"370_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00259-024-06915-3","volume":"52","author":"G Abikhzer","year":"2025","unstructured":"Abikhzer G, Treglia G, Pelletier-Galarneau M, Buscombe J, Chiti A, Dibble EH, et al. EANM\/SNMMI guideline\/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0. Eur J Nucl Med Mol Imaging. 2025;52(2):510\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"370_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0162-0134(01)00340-3","volume":"88","author":"JP Andr\u00e9","year":"2002","unstructured":"Andr\u00e9 JP, M\u00e4cke H, Kaspar A, K\u00fcnnecke B, Zehnder M, Macko L. In vivo and in vitro (27)Al NMR studies of aluminum(III) chelates of triazacyclononane polycarboxylate ligands. J Inorg Biochem. 2002;88(1):1\u20136. https:\/\/doi.org\/10.1016\/s0162-0134(01)00340-3.","journal-title":"J Inorg Biochem"},{"issue":"1","key":"370_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41181-021-00141-0","volume":"6","author":"SJ Archibald","year":"2021","unstructured":"Archibald SJ, Allott L. The aluminium-18Ffluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules. EJNMMI Radiopharm Chem. 2021;6(1):30. https:\/\/doi.org\/10.1186\/s41181-021-00141-0.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"370_CR4","doi-asserted-by":"publisher","unstructured":"Baker RA, editor. Trace Inorganics In Water [Internet]. WASHINGTON, D.C.: AMERICAN CHEMICAL SOCIETY; 1968 [cited 2025 Jun 20]. Available from: https:\/\/pubs.acs.org\/doi\/book\/https:\/\/doi.org\/10.1021\/ba-1968-0073","DOI":"10.1021\/ba-1968-0073"},{"issue":"11","key":"370_CR7","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.peptides.2006.05.022","volume":"27","author":"CPJM Brouwer","year":"2006","unstructured":"Brouwer CPJM, Bogaards SJP, Wulferink M, Velders MP, Welling MM. Synthetic peptides derived from human antimicrobial peptide Ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice. Peptides. 2006;27(11):2585\u201391.","journal-title":"Peptides"},{"key":"370_CR5","doi-asserted-by":"crossref","unstructured":"Brouwer C, Sarda-Mantel L, Meulemans A, Guludec D, Welling M. The Use of Technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging. Mini-Rev Med Chem. 2008;8(10):1039\u201352","DOI":"10.2174\/138955708785740670"},{"issue":"3","key":"370_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1021\/acs.bioconjchem.6b00012","volume":"27","author":"F Cleeren","year":"2016","unstructured":"Cleeren F, Lecina J, Billaud EMF, Ahamed M, Verbruggen A, Bormans GM. New chelators for low temperature Al(18)F-Labeling of biomolecules. Bioconjug Chem. 2016;27(3):790\u20138. https:\/\/doi.org\/10.1021\/acs.bioconjchem.6b00012.","journal-title":"Bioconjug Chem"},{"issue":"9","key":"370_CR10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1021\/bc200175c","volume":"22","author":"CA D\u2019Souza","year":"2011","unstructured":"D\u2019Souza CA, McBride WJ, Sharkey RM, Todaro LJ, Goldenberg DM. High-yielding aqueous 18F-labeling of peptides via Al18F chelation. Bioconjug Chem. 2011;22(9):1793\u2013803. https:\/\/doi.org\/10.1021\/bc200175c.","journal-title":"Bioconjug Chem"},{"key":"370_CR9","doi-asserted-by":"publisher","unstructured":"Dam JH, Langkj\u00e6r N, Baun C, Olsen BB, Nielsen AY, Thisgaard H. Preparation and Evaluation of 18FAlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to 68GaGa-DOTA\/NOTA-NOC. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27206818","DOI":"10.3390\/molecules27206818"},{"issue":"1","key":"370_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11144-015-0892-6","volume":"116","author":"E Farkas","year":"2015","unstructured":"Farkas E, Fodor T, K\u00e1lm\u00e1n FK, Tircs\u00f3 G, T\u00f3th I. Equilibrium and dissociation kinetics of the [Al(NOTA)] complex [al(nota)]NOTA\u2009=\u20091,4,7-triazacyclononane-1,4,7-triacetate). Reac Kinet Mech Cat. 2015;116(1):19\u201333. https:\/\/doi.org\/10.1007\/s11144-015-0892-6.","journal-title":"Reac Kinet Mech Cat"},{"issue":"8","key":"370_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2174\/138161212799315821","volume":"18","author":"G Ferro-Flores","year":"2012","unstructured":"Ferro-Flores G, Ocampo-Garcia BE, Melendez-Alafort L. Development of specific radiopharmaceuticals for infection imaging by targeting infectious micro-organisms. Curr Pharm Des. 2012;18(8):1098\u2013106. https:\/\/doi.org\/10.2174\/138161212799315821.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"370_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40336-016-0178-7","volume":"4","author":"G Ferro-Flores","year":"2016","unstructured":"Ferro-Flores G, Avila-Rodr\u00edguez MA, Garc\u00eda-P\u00e9rez FO. Imaging of bacteria with radiolabeled Ubiquicidin by SPECT and PET techniques. Clin Transl Imaging. 2016;4(3):175\u201382. https:\/\/doi.org\/10.1007\/s40336-016-0178-7.","journal-title":"Clin Transl Imaging"},{"issue":"2","key":"370_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.nucmedbio.2008.11.003","volume":"36","author":"M Gandomkar","year":"2009","unstructured":"Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH, et al. Clinical evaluation of antimicrobial peptide [99mTc\/Tricine\/HYNIC0]ubiquicidin 29\u201341 as a human-specific infection imaging agent. Nucl Med Biol. 2009;36(2):199\u2013205.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"370_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41181-018-0039-y","volume":"3","author":"J Giglio","year":"2018","unstructured":"Giglio J, Zeni M, Savio E, Engler H. Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform. EJNMMI Radiopharm Chem. 2018;3(1):4. https:\/\/doi.org\/10.1186\/s41181-018-0039-y.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"370_CR16","unstructured":"Ioppolo R, Morandeau, Leedman P. Aluminum-[18F]Flouride labeled radiopharmaceuticals - preparation and evaluation in vitro and in vivo. Orlando. 2018 25\u201327."},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"117482","DOI":"10.1016\/j.ejmech.2025.117482","volume":"289","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Wang Q, Feng J, Yin G, Han P, Ruan Q, et al. A novel Al18F-labelled NOTA-modified Ubiquicidin 29\u201341 derivative as a bacterial infection PET imaging agent. Eur J Med Chem. 2025;289:117482.","journal-title":"Eur J Med Chem"},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.apradiso.2018.01.006","volume":"135","author":"K Kersemans","year":"2018","unstructured":"Kersemans K, de Man K, Courtyn J, van Royen T, Piron S, Moerman L, et al. Automated radiosynthesis of Al18FPSMA-11 for large scale routine use. Appl Radiat Isot. 2018;135:19\u201327. https:\/\/doi.org\/10.1016\/j.apradiso.2018.01.006.","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"370_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s13277-011-0250-x","volume":"33","author":"P Laverman","year":"2012","unstructured":"Laverman P, D\u2019Souza CA, Eek A, McBride WJ, Sharkey RM, Oyen WJG, et al. Optimized labeling of NOTA-conjugated octreotide with F-18. Tumour Biol. 2012;33(2):427\u201334. https:\/\/doi.org\/10.1007\/s13277-011-0250-x.","journal-title":"Tumour Biol"},{"issue":"7","key":"370_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2967\/jnumed.118.218941","volume":"60","author":"S L\u00fctje","year":"2019","unstructured":"L\u00fctje S, Franssen GM, Herrmann K, Boerman OC, Rijpkema M, Gotthardt M, Heskamp S. In vitro and in vivo characterization of an 18F-AlF-Labeled PSMA ligand for imaging of PSMA-Expressing xenografts. J Nucl Med. 2019;60(7):1017\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.218941.","journal-title":"J Nucl Med"},{"key":"370_CR21","doi-asserted-by":"publisher","unstructured":"Magrini L, Gagliano G, Travaglino F, Vetrone F, Marino R, Cardelli P et al. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med CCLM [Internet]. 2014 Jan 1 [cited 2025 Feb 14];52(10). Available from: https:\/\/www.degruyter.com\/document\/doi\/https:\/\/doi.org\/10.1515\/cclm-2014-0210\/html","DOI":"10.1515\/cclm-2014-0210\/html"},{"issue":"3","key":"370_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/S0006-291X(88)81266-X","volume":"155","author":"RB Martin","year":"1988","unstructured":"Martin RB. Ternary hydroxide complexes in neutral solutions of Al3\u2009+\u2009and F-. Biochem Biophys Res Commun. 1988;155(3):1194\u2013200. https:\/\/doi.org\/10.1016\/S0006-291X(88)81266-X.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"370_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2967\/jnumed.108.060418","volume":"50","author":"WJ McBride","year":"2009","unstructured":"McBride WJ, Sharkey RM, Karacay H, D\u2019Souza CA, Rossi EA, Laverman P, et al. A novel method of 18F radiolabeling for PET. J Nucl Med. 2009;50(6):991\u20138. https:\/\/doi.org\/10.2967\/jnumed.108.060418.","journal-title":"J Nucl Med"},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jpba.2018.06.064","volume":"159","author":"A Mukherjee","year":"2018","unstructured":"Mukherjee A, Bhatt J, Shinto A, Korde A, Kumar M, Kamaleshwaran K, et al. 68Ga-NOTA-ubiquicidin fragment for PET imaging of infection: from bench to bedside. J Pharm Biomed Anal. 2018;159:245\u201351. https:\/\/doi.org\/10.1016\/j.jpba.2018.06.064.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"370_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0162-0134(00)80290-1","volume":"14","author":"KS Rajan","year":"1981","unstructured":"Rajan KS, Mainer S, Rajan NL, Davis JM. Studies on the chelation of aluminum for Neurobiological application. J Inorg Biochem. 1981;14(4):339\u201350. https:\/\/doi.org\/10.1016\/s0162-0134(00)80290-1.","journal-title":"J Inorg Biochem"},{"issue":"3","key":"370_CR26","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10967-024-09377-x","volume":"333","author":"CRP Santos","year":"2024","unstructured":"Santos CRP, Fuscaldi LL, Durante ACR, de Barboza MF, Malavolta L. New approach for in-house production of [68Ga]Ga-NOTA-UBI(29\u201341) using a titanium dioxide column-based generator. J Radioanal Nucl Chem. 2024;333(3):1253\u201362. https:\/\/doi.org\/10.1007\/s10967-024-09377-x.","journal-title":"J Radioanal Nucl Chem"},{"issue":"23","key":"370_CR27","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1039\/c0dt01594f","volume":"40","author":"GE Smith","year":"2011","unstructured":"Smith GE, Sladen HL, Biagini SCG, Blower PJ. Inorganic approaches for radiolabelling biomolecules with fluorine-18 for imaging with positron emission tomography. Dalton Trans. 2011;40(23):6196\u2013205. https:\/\/doi.org\/10.1039\/c0dt01594f.","journal-title":"Dalton Trans"},{"issue":"1","key":"370_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41181-019-0084-1","volume":"5","author":"T Tshibangu","year":"2020","unstructured":"Tshibangu T, Cawthorne C, Serdons K, Pauwels E, Gsell W, Bormans G, et al. Automated GMP compliant production of 18FAlF-NOTA-octreotide. EJNMMI Radiopharm Chem. 2020;5(1):4. https:\/\/doi.org\/10.1186\/s41181-019-0084-1.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"5","key":"370_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/j.semnuclmed.2019.07.001","volume":"49","author":"K Vermeulen","year":"2019","unstructured":"Vermeulen K, Vandamme M, Bormans G, Cleeren F. Design and challenges of radiopharmaceuticals. Semin Nucl Med. 2019;49(5):339\u201356.","journal-title":"Semin Nucl Med"},{"issue":"5","key":"370_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/acs.bioconjchem.1c00177","volume":"32","author":"Z Zha","year":"2021","unstructured":"Zha Z, Choi SR, Ploessl K, Alexoff D, Zhao R, Zhu L, Kung HF. Radiolabeling optimization and preclinical evaluation of the new PSMA imaging agent 18FAlF-P16-093. Bioconjug Chem. 2021;32(5):1017\u201326. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00177.","journal-title":"Bioconjug Chem"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00370-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-025-00370-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00370-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:38:06Z","timestamp":1781613486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41181-025-00370-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1186\/s41181-025-00370-7","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}